 |
|
|
| |
In Vitro Efficacy and Resistance Profiling of Protease Inhibitors Against a Novel HCV Genotype 3a Replicon
|
| |
| |
Reported by Jules Levin
International Workshop on HIV & Hepatitis Virus Drug Resistance and Curative Strategies, June 4-8, 2013, Toronto, Canada
Katie Chan1, Mei Yu1, Betty Peng1, Amoreena Corsa1, Angela Worth1, Ruoyu Gong1, Simin Xu1, Xiaowu Chen2, Todd C. Appleby2, James Taylor3, William E. Delaney1, Guofeng Cheng1
1Biology, Gilead Sciences Inc., Foster City, CA, United States 2Structural Chemistry, Gilead Sciences Inc., Foster City, CA, United States 3Medicinal Chemistry, Inc., Foster City, CA, United States
|
| |
|
|
|
|
|
